Publications


PBI-S: Standard versions for skin diseases including, among others, acne vulgaris, atopic eczema, and psoriasis vulgaris


Validation (different skin diseases):

Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Schäfer I, Reusch M, Mielke V, Rustenbach SJ: The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 301(8):561-71, 2009.

pubmed

Validation (psoriasis):

Feuerhahn J, Blome C, Radtke MA, Augustin M. Validation of the Patient Benefit Index for the Assessment of Patient- Relevant Benefit in the Treatment of Psoriasis. Arch Dermatol Res 304 (6):433-41, 2012.

pubmed

Validation (acne vulgaris):

Augustin M, Reich C, Schaefer I, Zschocke I, Rustenbach SJ: Entwicklung und Validierung eines neuen Instrumentes zur Erfassung patientendefinierten Nutzens in der Therapie der Akne. J Dtsch Dermatol Ges 6(2): 113–20, 2008. — Article is also available in English (Development and validation of a new instrument for the assessment of patient-defined benefit in the treatment of acne). .

pubmed

Subscales:

Blome C, Augustin M, Behechtnejad J, Rustenbach SJ: Dimensions of Patient Needs in Dermatology: Subscales of the Patient Benefit Index. Arch Dermatol Res 303(1), 11-17, 2011.

pubmed

PBI 2.0: Short version for skin diseases including atopic dermatitis, psoriasis, ulcus cruris, and vitiligo

Topp J, Augustin M, von Usslar K, Gosau R, Reich K, Reusch M, Blome C (2018). Measuring Patient Needs and Benefits in Dermatology using the ‘Patient Benefit Index 2.0’ – A Validation Study. Acta Derm Venereol. 99(2):211-7, 2019.

pubmed

PBI-AH: Aged skin

Lohrberg D, Blaak J, Liebsch J, Staib P, Wohlfart R, Lüttje D, Schürer NY, Augustin M, Blome C.Development and Validation of the Patient Benefit Index for the Dermatocosmetic Treatment of Aged Skin. Arch Dermatol Res 308(5):319-24, 2016.

pubmed

PBI-AR: Allergic rhinitis

Franzke N, Schäfer I, Jost K, Blome C, Rustenbach SJ, Reich K, Reusch M, Maurer M, Augustin M: A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis. Allergy. May;66(5):665-70, 2011.

pubmed

Demoly P, Aubier M, de Blay F, Wessel F, Clerson P, Maigret P: Evaluation of patients’ expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index – the benefica study. Allergy Asthma Clin Immunol. Feb 26;11(1):8, 2015.

pubmed

PBI-HE: Chronic hand eczema

Blome C, Maares J, Diepgen T, Rustenbach SJ, Augustin M: Measurement of patient-relevant benefits in the treatment of chronic hand eczema – a novel approach. Contact Dermatitis 61: 39-45, 2009.

pubmed

PBI-W: Chronic wounds

Augustin M, Blome C, Zschocke I, Schäfer I, Koenig S, Rustenbach SJ, Herberger K: Benefit evaluation in the therapy of chronic wounds from the patients’ perspective-development and validation of a new method. Wound Repair Regen: 20(1):8-14, 2012.

pubmed

PBI-K: Cosmetic indications

Augustin M, Schäfer I, Rabini S, Lee-Seifert C, Radtke M, Rustenbach SJ: Assessing the value of supportive skin care: development and validation of an instrument for evaluating patient-relevant benefit. Dermatology 218(3):255-9, 2009.

pubmed

PBI-L: Lymphedema

Blome C, Augustin M, Heyer K, Knöfel J, Cornelsen H, Purwins S, Herberger K: Evaluation of patient-relevant outcomes of lymphedema and lipedema treatment: development and validation of a new benefit tool. Eur J Vasc Endovasc Surg 47(1):100-7, 2013.

pubmed

Duygu E, Bakar Y, Keser I. An Important Tool in Lymphedema Management: Validation of Turkish Version of the Patient Benefit Index-Lymphedema. Lymphat Res Biol 18(1):49-5, 2020

pubmed

PBI-MS: Multiple sclerosis

Beckmann H, Augustin M, Heesen C, Poettgen J, Blome C: Benefit evaluation in multiple sclerosis relapse treatment from the patients’ perspective – Development and validation of a new questionnaire. Mult Scler Relat Disord. 28:256-61, 2019

pubmed

NAPPA-PBI: Nail psoriasis

Augustin M, Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni G, Gniadecki R, Iversen L, Menter A, Michaelis-Wittern K, Morita A, Nakagawa H, Reich K: Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): Development and Validation of a Tool for Assessment of Nail Psoriasis Outcomes. Br J Dermatol 170:591-8, 2014

pubmed

PBI-POD: Peripheral artery occlusive disease

Zander N, Demirel EB, Augustin M, Sommer R, Debus ES, Breuer P, Blome C (2018). Development and validation of the Patient Benefit Index for peripheral arterial disease. VASA 47(3):219-226, 2018

pubmed

PBI-P: Pruritus

Blome C, Augustin M, Siepmann D, Phan NQ, Rustenbach SJ, Ständer S. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol 161(5):1143-8, 2009

pubmed

PBI-Vit: Vitiligo

Augustin M, Gajur AI, Reich C, Rustenbach SJ, Schaefer I. Benefit Evaluation in Vitiligo treatment: Development and Validation of a Patient-Defined Outcomes Questionnaire.. Dermatology 217: 101-106, 2008

pubmed